JTEKT India Ltd Q4 FY2025 Concall Summary

Source transcript PDF: https://www.stockscans.in/document/tj0pv4gtzs465jimdjg0twul.pdf

Key Takeaways


Margin Bridge: The One-Time Hit Thesis

Sugisawa: "Most of these cost impacts are exceptional and at one time."

CVJ: The Margin Expansion Story

Chanana: "We expect these to be better sir. Despite competition being there, we expect that the margins will improve. Two ways, not only through the customer negotiation but also that we are able to do our own cost reduction activities."

EV & New Business Wins


Capacity & Capex Cycle


Demand Environment & Revenue Outlook

Chanana: "Look, normally we do not have futuristic assumptions on this investor call. But I can only give you the past number. We touched 10%, 11% earlier. But I cannot. We will not like to put any futuristic number on the table at this point of time. But we know that how important this is for our profitability."

Quality & Operational Discipline

Chanana: "He say it happens, it doesn't happen. We do not allow it to happen. That's our promise to you. We will be more quality conscious; our quality team is taking it as a challenge that we do not face this situation again."

Guidance & Commitments

CommitmentSpecificsTimeline
US export margin drag reversal0.6 pp impact from US export decline not to recur; May volumes already at last year's Q1 levelCurrent year (FY26)
Process cost provision recoverySignificant recovery from customers expected on vendor-claim provisions (0.4 pp impact)Settlement process ongoing, no fixed date
CVJ commercial productionNew CVJ line capex of ₹90–100 crore; commercial production beginsJuly 2025
CVJ market shareExpand from ~5% to 7.5–10%"Within a year or so"
Capacity utilizationDip to ~85% during ramp-up, then return to ~100%By March 2027
Employee cost reductionEmployee costs expected to reduce; optimization plans on the tableNext year (FY26)
Admin cost containmentAdmin costs not to rise with new capacity; only depreciation will increaseOngoing

Key Metrics

MetricQ4 FY25 / FY25
Revenue growth7% YoY for FY25, vs passenger vehicle market growth of 3.7%
EBITDA margin7.6% for FY25, down from 9.5% in FY24
Employee cost as % of sales10.4% for FY25, up from 10.1% in FY24
Administration cost₹45.5 cr for FY25, down from ₹49.4 cr in FY24
Export sales share2.4% of overall sales for FY25, down from 4% in FY24; margin impact of 0.6%
Product recall impact on margin0.3% for FY25, recall of ~2,500 manual gear units
Process cost provision impact on margin0.4% for FY25, provisions for vendor price increases pending customer recovery
Total one-off margin decline1.8% to 1.9% for FY25, from external and exceptional factors
CAPEX incurred₹287 cr for FY25: ₹191 cr new capacity, ₹39 cr maintenance, ₹7 cr IT, ₹50 cr dyes
Cash generation₹156 cr for FY25
Debt equity ratio0.17 as of FY25 end
Fixed asset coverage ratio (FACR)~4x, maintained for last 2-3 years
Revenue mix – Maruti Suzuki56% of FY25 revenue
Revenue mix – Toyota12% of FY25 revenue
Revenue mix – Honda8% of FY25 revenue
Revenue mix – Mahindra & Mahindra8% of FY25 revenue
Revenue mix – Tata2% of FY25 revenue
Revenue mix – Renault Nissan3% of FY25 revenue
Revenue mix – Isuzu1% of FY25 revenue
Revenue mix – Stellantis1% of FY25 revenue
Revenue mix – Exports2.4% of FY25 revenue
CPS line capacity utilization110% currently
Manual gear line capacity utilization92% currently
New product development testing charges₹11.2 cr spent in FY25
JTEKT Corp indicated India CAPEX~₹1,800 cr (3,000 crore Yen) till FY28, with flexibility up to that from a base plan of ~₹1,500 cr
Gujarat facility CAPEX~₹250 cr initially, may go up to ₹600 cr
Gujarat facility timelineExpansion expected to start from FY27-28
CVJ market share~5% currently, expected to reach 7.5-10% within a year or so
Maruti Suzuki EV supply100% supplier for the upcoming EV model, supplying manual gear, CPS, and CVJ; production expected to start around July 2025